Additionally, we found that phosphoinositide 3‐kinase (PI3K) and protein kinase B (Akt) exhibited strong genetic correlations with the core targets, suggesting that the PI3K‐Akt signaling pathway may be a key mechanism in GGD's treatment of COVID‐19 (Figure S1A,B, Supporting Information). The gene discussed is AKT1; the disease is COVID-19.